(2026). Metabolic Syndrome Predicts Chemotherapy Resistance and Poor Prognosis in Epithelial Ovarian Cancer: A Retrospective Observational Cohort Study. International Journal of Women's Health.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Metabolic Syndrome Predicts Chemotherapy Resistance and Poor Prognosis in Epithelial Ovarian Cancer: A Retrospective Observational Cohort Study."
International Journal of Women's Health 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Metabolic Syndrome Predicts Chemotherapy Resistance and Poor Prognosis in Epithelial Ovarian Cancer: A Retrospective Observational Cohort Study."
International Journal of Women's Health, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.